These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26744866)

  • 1. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion.
    Zou Y; Guo CG; Zhang MM
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4751-61. PubMed ID: 26744866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
    Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
    Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Wang B; Xu H; Gao ZQ; Ning HF; Sun YQ; Cao GW
    Acta Radiol; 2008 Jun; 49(5):523-9. PubMed ID: 18568538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
    Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
    Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells.
    Xiao EH; Guo D; Bian DJ
    World J Gastroenterol; 2009 Sep; 15(36):4582-6. PubMed ID: 19777619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.
    Zhang L; Liu FY; Fu JX; Duan F; Fan QS; Wang MQ
    Int J Clin Exp Pathol; 2014; 7(11):7775-81. PubMed ID: 25550815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF.
    Wu YY; Chen L; Wang GL; Zhang YX; Zhou JM; He S; Qin J; Zhu YY
    J Mol Histol; 2013 Aug; 44(4):433-45. PubMed ID: 23636606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of VEGF inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via VEGF/PI3K/AKT signaling pathway.
    Peng N; Gao S; Guo X; Wang G; Cheng C; Li M; Liu K
    Am J Transl Res; 2016; 8(2):1005-15. PubMed ID: 27158386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
    Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
    Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
    Raskopf E; Vogt A; Sauerbruch T; Schmitz V
    J Hepatol; 2008 Dec; 49(6):977-84. PubMed ID: 18845354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ShRNA knock-down of CXCR7 inhibits tumour invasion and metastasis in hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Zhao ZW; Fan XX; Song JJ; Xu M; Chen MJ; Tu JF; Wu FZ; Zhang DK; Liu L; Chen L; Ying XH; Ji JS
    J Cell Mol Med; 2017 Sep; 21(9):1989-1999. PubMed ID: 28429395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma.
    Lei HW; Huang BR; Cai J; Li CM; Shang CB; Liao ZY; Wan ZD
    Kaohsiung J Med Sci; 2022 Aug; 38(8):781-789. PubMed ID: 35467082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor.
    Deng G; Zhao DL; Li GC; Yu H; Teng GJ
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):824-32. PubMed ID: 21671151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF Silencing Inhibits Human Osteosarcoma Angiogenesis and Promotes Cell Apoptosis via PI3K/AKT Signaling Pathway.
    Zhao J; Zhang ZR; Zhao N; Ma BA; Fan QY
    Cell Biochem Biophys; 2015 Nov; 73(2):519-525. PubMed ID: 27352347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endostatin inhibits angiogenesis in hepatocellular carcinoma after transarterial chemoembolization.
    Bao Y; Feng WM; Tang CW; Zheng YY; Gong HB; Hou EG
    Hepatogastroenterology; 2012; 59(117):1566-8. PubMed ID: 22456329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intratumoral microvessel density and expression of vascular endothelial growth factor in hepatocellular carcinoma after chemoembolization].
    Shao G; Wang J; Zhou K; Yan Z
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):170-3. PubMed ID: 12113668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization.
    Yi J; Liao X; Yang Z; Li X
    J Tongji Med Univ; 2001; 21(4):321-2, 331. PubMed ID: 12539559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
    Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K
    Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.